Pneumonia clinical trials
31 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- iNO300 Therapy in Critically Ill Patients With Pneumonia
- PICNIC Study - PatIent Centered aNtIbiotic Courses in Children With Medical Complexity
- A Clinical Trial to Evaluate agenT-797 Plus Standard of Care in Participants With Severe Pneumonia With Moderate to Severe Acute Hypoxemic Respiratory Failure
- Extending Dental Care to Nursing Home Residents to Reduce Mouth Infections and Incidence of Pneumonia and Improve Diabetic Glucose Control
- Phase 2a Multiple Ascending Dose Study in Hospitalized Patients With Pneumonia.
- How OMT Benefits Newly Diagnosed Patients With Respiratory Illness When Given Alongside Other Standard Care.
- Home Hospital for Suddenly Ill Adults
- Lung Ultrasound for Guiding Antibiotic Use in Pediatric Pneumonia
- Clinical Utility of Portable Dynamic Chest X Ray (DDR) in the ICU
- Use of Hyperpolarized 129Xe MR Lung Imaging in Infants
- Performance of New Diagnostic Methods in Older Adults With Pneumonia
- A Study to Learn About How 20-Valent Pneumococcal Conjugate Vaccine Works in a Real-world Setting
- Creation of a Biospecimen Repository From Patients With Interstitial Lung Diseases (ILD)
- Study of Lung Proteins in Patients With Pneumonia
- The APS Phenotyping Study
- Predicting the Need for Prolonged Respiratory Support in Neonates Delivered in a Lower-Level NICU Setting
- End Diagnostic Overshadowing:Addressing Ableism in Diagnoses
- Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
- Adaptation and Pilot Implementation of ePNa Clinical Decision Support for Utah Urgent Care Clinics
- Immune Defense Protein Impact On Respiratory Immune Outcomes
- Follow-up Automatically vs. As-Needed Comparison (FAAN-C) Trial
- Reducing Overuse of Antibiotics With Decision Support
- The Role of Circadian Clock Proteins in Innate and Adaptive Immunity
- The Effects of Endotracheal Suctioning on Pain and Serum Markers
- Ketogenic Approach to Restore Muscle in Older Patients With Community-Acquired Pneumonia - KARMA-P Trial
- Personalized Ventilator Settings for Patients on ECMO
- Self-directed Mobile Mindfulness to Address ICU Survivors' Psychological Distress: the Lift RCT
- Reducing Overuse of Antibiotics at Discharge Home
- Trial of Reducing Inpatient Antibiotic Durations in Children
- Analysis of the Virtual Acute Care at Home Experience
- Safety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Prior Pneumococcal Vaccination
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Pneumonia” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.